BeiGene Ltd. Cash Flow-to-Debt Ratio
BeiGene Ltd. cash flow-to-debt ratio. BeiGene Ltd. (49B) has a Cash Flow-to-Debt Ratio of 0.02x as of March 2025, meaning its operating cash flow of €44.08 Million could theoretically repay 0% of its total liabilities (€2.34 Billion) in one year. Check BeiGene Ltd. (49B) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BeiGene Ltd. (2016–2024)
Cash flow-to-debt ratio of BeiGene Ltd. from 2016 to 2024. Historical debt coverage capacity for BeiGene Ltd. across 9 annual periods. Check 49B cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
BeiGene Ltd. Cash Flow-to-Debt Ratio by Year (2016–2024)
BeiGene Ltd. cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for BeiGene Ltd.. For the full cash flow conversion analysis, see BeiGene Ltd. (49B) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.05x | €-140.63 Million | €2.59 Billion | ▲ +90.2% |
| 2023 | -0.55x | €-1.25 Billion | €2.27 Billion | ▲ +26.3% |
| 2022 | -0.75x | €-1.50 Billion | €2.00 Billion | ▼ -38.7% |
| 2021 | -0.54x | €-1.30 Billion | €2.40 Billion | ▲ +27.1% |
| 2020 | -0.74x | €-1.28 Billion | €1.73 Billion | ▲ +37.4% |
| 2019 | -1.18x | €-750.27 Million | €633.93 Million | ▼ -7.2% |
| 2018 | -1.10x | €-547.72 Million | €496.04 Million | ▼ -3236.7% |
| 2017 | 0.04x | €12.75 Million | €362.25 Million | ▲ +102.1% |
| 2016 | -1.69x | €-89.51 Million | €52.91 Million | — |